Miv Therapeutics (India) Private Limited, a amalgamated private limited company, was established on 01 August 2006 in Surat, Gujarat, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U33112GJ2006PTC048811. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.22 Cr.
Formerly known as Biosync Scientific Private Limited. It upholds a compliant status. Its leadership includes Murlidhar Baliram Bendale (Director), Mathew Thundiyl Thomas (Director), Brian Savio Lancelot (Director). Past directors included Abhishek Sharma, Murlidhar Baliram Bendale, Mathew Thundiyl Thomas. It holds no open charges and ₹15.86 Cr settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Plot No. 136-B, Surat Special Economic Zone, Road No. 4, G.I.D.C, Sachin,, Surat, Gujarat, 394230.
U33112GJ2006PTC048811
048811
01 August 2006
₹10.00 Cr
₹8.22 Cr
Roc Ahmedabad
Unlisted
Amalgamated
Explore comprehensive insights into Miv Therapeutics (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Murlidhar Baliram Bendale | Director | 22 May 2012 | Current |
| Mathew Thundiyl Thomas | Director | 24 Aug 2011 | Current |
| Brian Savio Lancelot | Director | 24 Aug 2011 | Current |
| Rajesh Hiralal Shrivas | Director | 24 Aug 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | 16 Jun 2011 | Past |
| Pramod Abcsdd | Nominee Director | 10 Feb 2014 | Past |
| Pramod Abcsdd | Nominee Director | 10 Feb 2014 | Past |
| Pramod Abcsdd | Nominee Director | 10 Feb 2014 | Past |
| Pramod Abcsdd | Nominee Director | 10 Feb 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 15 Jun 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Miv Therapeutics (India) Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 10.03% increase. The company also saw a substantial fall in profitability, with a 42.95% decrease in profit. The company's net worth moved up by a moderate rise of 3.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Miv Therapeutics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹158,562,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jan 2013 | The Shamrao Vithal Co-Operative Bank Limited | ₹2.00 Cr | Satisfied |
| 02 Jan 2013 | The Shamrao Vithal Co-Operative Bank Limited | ₹9.00 M | Satisfied |
| 01 Dec 2006 | Central Bank Of India | ₹5.06 Cr | Satisfied |
| 04 Nov 2006 | Central Bank Of Indoa | ₹9.25 M | Satisfied |
| 04 Nov 2006 | Central Bank Of Indoa | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Miv Therapeutics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Miv Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Miv Therapeutics (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Miv Therapeutics (India) Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.
Miv Therapeutics (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Ahmedabad. was recorded as a recent event.
Madhavi Kishor Jawale was appointed as a Company Secretary was appointed as a Company Secretary on 02 Jul 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.
The activity Madhavi Yogesh Mahajan was appointed as a Company Secretary was appointed as a Company Secretary on 02 Jul 2018 & has been associated with this company since 7 years 6 months . was completed.
Progress on A charge registered on 02 Jan 2013 via Charge ID 10399986 with The Shamrao Vithal Co-Operative Bank Limited was fully satisfied on 05 Sep 2013. was documented.
A charge registered on 02 Jan 2013 via Charge ID 10400735 with The Shamrao Vithal Co-Operative Bank Limited was fully satisfied on 05 Sep 2013. was recorded as a recent event.
The CIN of Miv Therapeutics (India) Private Limited is U33112GJ2006PTC048811.
Miv Therapeutics (India) Private Limited is headquartered at Plot No. 136-B, Surat Special Economic Zone, Road No. 4, G.I.D.C, Sachin,, Surat, Gujarat, 394230.
Miv Therapeutics (India) Private Limited was incorporated on 01 August 2006.
The current directors of Miv Therapeutics (India) Private Limited are
The primary industry of Miv Therapeutics (India) Private Limited is Manufacturing.
Miv Therapeutics (India) Private Limited is unlisted.
The authorized capital of Miv Therapeutics (India) Private Limited is ₹10.00 Cr, and the paid-up capital is ₹8.22 Cr.
The compliance status of Miv Therapeutics (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX